Fetal and neonatal presentation of long QT syndrome

PACE - Pacing and Clinical Electrophysiology

Volumn 35, Issue 4, 2012, Pages e87-e90

  Komarlu, Rukmini ^a   Beerman, Lee ^a   Freeman, David ^b   Arora, Gaurav ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b Department of Pediatric Cardiology   (United States)

Author keywords

long QT; pediatrics

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ISOPRENALINE; LIDOCAINE; PROPRANOLOL; ANTIARRHYTHMIC AGENT; ERG1 POTASSIUM CHANNEL; POTASSIUM CHANNEL HERG;

ARTICLE; CASE REPORT; ELECTROCARDIOGRAPHY; FEMALE; FETUS; FETUS ECHOGRAPHY; FETUS HYDROPS; FOLLOW UP; GENETIC SCREENING; HEART VENTRICLE ARRHYTHMIA; HUMAN; LONG QT SYNDROME; MITRAL VALVE REGURGITATION; NEWBORN; PATENT DUCTUS ARTERIOSUS; PROGNOSIS; PULMONARY HYPERTENSION; RESUSCITATION; TACHYCARDIA; TORSADE DES POINTES; TRICUSPID VALVE REGURGITATION; FETUS DISEASE; GENETICS; MALE; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ANTI-ARRHYTHMIA AGENTS; ELECTROCARDIOGRAPHY; ETHER-A-GO-GO POTASSIUM CHANNELS; FEMALE; FETAL DISEASES; FETUS; HUMANS; HYDROPS FETALIS; INFANT, NEWBORN; ISOPROTERENOL; LIDOCAINE; LONG QT SYNDROME; MALE; TORSADES DE POINTES; TREATMENT OUTCOME;

EID: 84864883849     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2011.03040.x     Document Type: Article

References (12)

1. Schwartz PJ, Stramba-Badiale M, Crotti L, Pedrazzini M, Besana A, Bosi G, Gabbarini F, et al., Prevalence of the congenital long-QT syndrome. Circulation 2009; 120: 1761-1767.
2. Schulze-Bahr E, Fenge H, Etzrodt D, Haverkamp W, Mönnig G, Wedekind H, Breithardt G, et al,. Long QT syndrome and life threatening arrhythmia in a newborn: Molecular diagnosis and treatment response. Heart 2004; 90: 13-16.
3. Donofrio MT, Gullquist SD, O'Connell NG, Redwine FO,. Fetal presentation of congenital long QT syndrome. Pediatr Cardiol 1999; 20: 441-444.
4. Ohkuchi A, Shiraishi H, Minakami H, Eguchi Y, Izumi A, Sato I,. Fetus with long QT syndrome manifested by tachyarrhythmia: A case report. Prenat Diagn 1999; 19: 990-992.
5. Mache CJ, Beitzke A, Haidvogl Jr. M, Gamillscheg A, Suppan C, Stein JI,. Perinatal manifestations of idiopathic long QT syndrome. Pediatr Cardiol 1996; 17: 118-121.
6. Goldenberg I, Moss AJ,. Long QT syndrome. J Am Coll Cardiol 2008; 51: 2291-2300.
7. Antzelevitch C., Sympathetic modulation of the long QT syndrome. Eur Heart J 2002; 23: 1246-1252.
8. Raviña T, Raviña M, Gutierrez J,. Isoproterenol enhancement of IKs current in Amiodarone-induced long QT syndrome. Int J Cardiol 2009; 133: 402-406.
9. Yamamoto H, Bando S, Nishikado A, Shinohara A, Hamai K, Yamamoto K, Ikefuji H, et al,. The efficacy of isoproterenol on quinidine induced torsade de pointes. Tokushima J Exp Med 1991; 38: 1-4.
10. Watanabe A, Morita H, Kusano K, Banba K, Nishii N, Nagase S, Nakamura K, et al,. Low dose isoproterenol is effective therapy for repetitive ventricular arrhythmia in patients with Brugada syndrome. Eur Heart J 2006; 27: 1579-1583.
11. Horner JM, Kinoshita M, Webster TL, Haglund CM, Friedman PA, Ackerman MJ,. Implantable cardioverter defibrillator therapy for congenital long QT syndrome: A single-center experience. Heart Rhythm 2010; 7: 1616-1622.
12. Schwartz PJ, Spazzolini C, Priori SG, Crotti L, Vicentini A, Landolina M, Gasparini M, et al,. Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: Data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) registry. Circulation 2010; 122: 1272-1282. Epub 2010 Sep 13.